Company

Aceragen, Inc. (0000861838)

Standardized SEC financial data for Aceragen, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000861838 · Biological Products, (No Diagnostic Substances).

Operating margin

-572.1%

Net margin

-480.5%

Return on equity

-197.5%

ROIC

-375.0%

Free cash flow

-$24.5M

Debt / equity

0.51×

Current ratio

0.83×

EPS (diluted)

$-7.18

Ratios for fiscal year 2022, standardized from SEC filings.

Income statement

USD	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022
Revenue	$902K	$662K	$1.4M	—	$0	$4.9M
R&D expense	$50.7M	$41.8M	$34.9M	$24.8M	$16.4M	$12.2M
SG&A expense	$15.6M	$15.4M	$12.5M	$11.9M

Balance sheet

USD	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022
Cash & equivalents	$112.9M	$71.4M	$42.8M	$37.7M	$32.5M	$12.0M
Total current assets	$116.6M	$72.8M	$46.3M	$41.4M	$34.0M	$17.9M
Property, plant & equipment	$1.5M	$207K	$97K	$44K

Cash flow

USD	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022
Operating cash flow	-$55.3M	-$51.9M	-$44.5M	-$33.8M	-$24.6M	-$24.5M
Capital expenditures	$206K	$75K	$11K	$8K	—	—
Free cash flow	-$55.5M	-$52.0M	-$44.5M	-$33.8M

Get 0000861838 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0000861838/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0000861838/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0000861838 filings on SEC EDGAR →